Skip to content

Vir Biotechnology

US · VIR #2824 by market cap Listed 2019
8.39 -0.48 -5.41%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
B+
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 8 analysts

Buy
Avg price target 22.43 +167.3%
Price target rangecurrent 8.39
Low17.00
Avg22.43
High30.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-11 Barclays -- Buy 30.00
2026-11-10 Morgan Stanley -- Buy 28.00
2026-11-10 Evercore -- Buy 25.00
2026-11-10 H.C. Wainwright -- Buy 22.00
2026-11-09 H.C. Wainwright -- Buy 22.00
2026-11-06 BofA Securities -- Buy 17.00
2026-11-05 TD Cowen -- Buy --
2026-11-05 Morgan Stanley -- Buy 25.00
2026-11-05 Evercore -- Buy 22.00
2026-11-05 Leerink Partners -- Buy 17.00
2026-11-05 Barclays -- Buy 30.00
2026-11-04 H.C. Wainwright -- Buy 22.00
2026-11-03 H.C. Wainwright -- Buy 22.00
2026-10-19 Barclays -- Buy 30.00
2026-10-15 H.C. Wainwright -- Buy 22.00
2026-10-14 H.C. Wainwright -- Buy 22.00
2026-10-08 Barclays -- Buy 30.00
2026-10-07 H.C. Wainwright -- Buy 22.00
2026-09-29 Leerink Partners -- Buy 17.00
2026-09-28 Needham -- Buy 18.00
2026-09-21 H.C. Wainwright -- Buy 20.00
2026-08-10 H.C. Wainwright -- Buy 20.00
2026-08-07 BofA Securities -- Buy 15.00
2026-08-06 Morgan Stanley -- Buy 25.00
2026-08-06 Evercore -- Buy 22.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-04 After close ±12.79% -6.37% (in line)
2026/Q2 2026-08-05 After close ±13.96% -3.79% (in line)
2026/Q1 2026-05-06 After close ±13.51% -9.91% (in line)
2025/Q4 2026-02-23 After close ±26.85% +27.73% (beat)
2025/Q3 2025-11-05 After close ±26.19% -5.19% (in line)
2025/Q2 2025-08-06 After close ±11.42% -14.37% (beat)
2025/Q1 2025-05-07 After close ±18.72% -3.57% (in line)
2024/Q4 2025-02-26 After close ±24.92% -11.85% (in line)
2024/Q3 2024-10-31 After close ±14.02% +23.63% (beat)
2024/Q2 2024-08-01 After close ±15.66% -5.34% (in line)
2024/Q1 2024-05-02 After close ±19.00% +13.18% (in line)
2023/Q4 2024-02-22 After close ±21.56% +11.94% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Vir Biotechnology discussion 0 comments

Add a comment